Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years - Concepedia

Concepedia

Publication | Open Access

Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years

DOI Full Paper Access

103

Citations

20

References

2013

Year

Dorothee Kieninger, Eric Sheldon, Wen‐Yuan Lin, Chong‐Jen Yu, José M. Bayas, Julian Gabor, Meral Esen, Jose Luis Fernandez Roure, Silvia Narejos Pérez, Carmen Alvarez Sanchez,

BMC Infectious Diseases

Abstract

Clinical Trials.gov: NCT01204671/114269.

References

	Year	Citations

Page 1